Inflation-linked cash flows and a capex supercycle suggest listed infrastructure remains mispriced as growth improves.

Even if the market didn’t reward Progressive in 2025, the fundamentals remained intact. PGR is still one of the best-in-class ...

Encouraging early clinical activity, including confirmed partial responses in multiple tumor types with different RAS mutations, coupled with promising safety and pharmacokinetics data, observed for ...

The season has not yet reached its midpoint, but this week, we’ll check in on those preseason over/unders from BetMGM (you ...

Strategic collaboration expands taletrectinib global reach with a leading oncology partnerEisai will receive exclusive development, registration and commercialization rights for taletrectinib for the ...

In early 2025, Target expanded its wellness assortment by adding 2,000 new products, with more than half priced under $10.

As mass-produced strike and FPV drones reshape battlefields from Ukraine to the Red Sea, the United States is scrambling to ...

Need some new winter bib tights to keep your legs warm while cycling? We put a range of options to the test to find out which ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and trades.

Two effective manipulatives that can be used to support fractions and base 10 learning are base 10 blocks and Cuisenaire rods ...